Global Flow Cytometry Solutions Market Growth (Status and Outlook) 2025-2031

The global Flow Cytometry Solutions market size is predicted to grow from US$ 4541 million in 2025 to US$ 7539 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.

Flow cytometry solutions refer to a range of products, instruments, reagents, and software used in the field of flow cytometry, a powerful analytical technique employed in biology, immunology, molecular biology, and clinical research. Flow cytometry allows for the quantitative analysis of cells and particles in a fluid medium. These solutions enable researchers to examine various properties of cells and particles, including size, granularity, surface markers, and intracellular molecules, with high precision and speed. Flow cytometry is widely used in fields such as immunology, cancer research, drug development, and diagnostics.

The continued development of flow cytometers capable of analyzing an increasing number of parameters simultaneously. High-parameter flow cytometry allows researchers to characterize complex cell populations with greater precision.

LPI (LP Information)' newest research report, the “Flow Cytometry Solutions Industry Forecast” looks at past sales and reviews total world Flow Cytometry Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Flow Cytometry Solutions sales for 2025 through 2031. With Flow Cytometry Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Flow Cytometry Solutions industry.

This Insight Report provides a comprehensive analysis of the global Flow Cytometry Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Flow Cytometry Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Flow Cytometry Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Flow Cytometry Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Flow Cytometry Solutions.

This report presents a comprehensive overview, market shares, and growth opportunities of Flow Cytometry Solutions market by product type, application, key players and key regions and countries.

Segmentation by Type:
Flow Cytometry Staining Protocol
Propidium Iodide Flow Cytometry Protocol
Others

Segmentation by Application:
Biological Industry
Chemical Industry
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BioSure
Analis
Thermo Fisher Scientific Inc.
Analog Devices, Inc.
PerkinElmer Inc.
Agilent
Sartorius AG
Miltenyi Biotec
Labcorp
Sysmex Europe SE
Curiox BioSystems
Bioanalytical Instruments
R&D Systems
MKS Instruments
CytoBuoy bv
Flowcytometry Solutions Pvt. Ltd

Please note: The report will take approximately 2 business days to prepare and deliver.